Interleukin-13 peptide vaccine induces protective humoral immunity in murine asthma models (Q50234200)

http://europepmc.org/abstract/PMC/5805505

28 February 2018

title

Interleukin-13 peptide vaccine induces protective humoral immunity in murine asthma models (English)

1 reference

http://europepmc.org/abstract/PMC/5805505

28 February 2018

author name string

Fengbo Wu

1

1 reference

http://europepmc.org/abstract/PMC/5805505

28 February 2018

Yan Huang

2

1 reference

http://europepmc.org/abstract/PMC/5805505

28 February 2018

Peng Zhang

3

1 reference

http://europepmc.org/abstract/PMC/5805505

28 February 2018

Chunting Wang

4

1 reference

http://europepmc.org/abstract/PMC/5805505

28 February 2018

Yaomei Tian

5

1 reference

http://europepmc.org/abstract/PMC/5805505

28 February 2018

Lian Lu

6

1 reference

http://europepmc.org/abstract/PMC/5805505

28 February 2018

Gu He

7

1 reference

http://europepmc.org/abstract/PMC/5805505

28 February 2018

Li Yang

8

1 reference

http://europepmc.org/abstract/PMC/5805505

28 February 2018

language of work or name

English

0 references

publication date

4 August 2017

1 reference

http://europepmc.org/abstract/PMC/5805505

28 February 2018

published in

Oncotarget

1 reference

http://europepmc.org/abstract/PMC/5805505

28 February 2018

volume

9

1 reference

http://europepmc.org/abstract/PMC/5805505

28 February 2018

issue

6

1 reference

http://europepmc.org/abstract/PMC/5805505

28 February 2018

page(s)

6678-6690

1 reference

http://europepmc.org/abstract/PMC/5805505

28 February 2018

cites work

NKT cell-dependent glycolipid-peptide vaccines with potent anti-tumour activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5805505

Anti-metastatic effect of the TM4SF5-specific peptide vaccine and humanized monoclonal antibody on colon cancer in a mouse lung metastasis model

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5805505

Recombinant heat shock protein 70 functional peptide and alpha-fetoprotein epitope peptide vaccine elicits specific anti-tumor immunity

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5805505

Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide GP2 vaccine in breast cancer patients to prevent recurrence

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5805505

Targeting Programmed Cell Death Using Small-Molecule Compounds to Improve Potential Cancer Therapy

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5805505

Exceptional antineoplastic activity of a dendritic-cell-targeted vaccine loaded with a Listeria peptide proposed against metastatic melanoma.

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5805505

Recent Advance in Tumor-associated Carbohydrate Antigens (TACAs)-based Antitumor Vaccines

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5805505

Multivalent Antigens for Promoting B and T Cell Activation.

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5805505

Design, synthesis and characterisation of mannosylated ovalbumin lipid core peptide self-adjuvanting vaccine delivery system

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5805505

Antibody induction directed against the tumor-associated MUC4 glycoprotein

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5805505

Covalent bond or noncovalent bond: a supramolecular strategy for the construction of chemically synthesized vaccines

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5805505

The effects of lebrikizumab in patients with mild asthma following whole lung allergen challenge.

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5805505

Recent mechanistic insights on glycoconjugate vaccines and future perspectives

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5805505

The development of synthetic antitumour vaccines from mucin glycopeptide antigens

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5805505

Structural basis of signaling blockade by anti-IL-13 antibody Lebrikizumab

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5805505

A phase II placebo-controlled study of tralokinumab in moderate-to-severe asthma

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5805505

A totally synthetic, self-assembling, adjuvant-free MUC1 glycopeptide vaccine for cancer therapy

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5805505

Variation of the glycosylation pattern in MUC1 glycopeptide BSA vaccines and its influence on the immune response

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5805505

Lebrikizumab treatment in adults with asthma

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5805505

Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5805505

Interleukin-13: central mediator of allergic asthma

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5805505

Water-soluble polymers coupled with glycopeptide antigens and T-cell epitopes as potential antitumor vaccines

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5805505

Direct peptide lipidation through thiol-ene coupling enables rapid synthesis and evaluation of self-adjuvanting vaccine candidates.

14 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5805505

Sustained suppression of IL-13 by a vaccine attenuates airway inflammation and remodeling in mice.

14 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5805505

Synthesis of fluorescein-labelled O-mannosylated peptides as components for synthetic vaccines: comparison of two synthetic strategies

14 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5805505

A potential immunotherapy approach: mucosal immunization with an IL-13 peptide-based virus-like particle vaccine in a mouse asthma model

14 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5805505

Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma

14 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5805505

Synthesis of a highly pure lipid core peptide based self-adjuvanting triepitopic group A streptococcal vaccine, and subsequent immunological evaluation

14 August 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/29467919

12 December 2020

Method for the synthesis of highly pure vaccines using the lipid core peptide system

1 reference

https://pubmed.ncbi.nlm.nih.gov/29467919

12 December 2020

A synthetic vaccine consisting of a tumor-associated sialyl-T(N)-MUC1 tandem-repeat glycopeptide and tetanus toxoid: induction of a strong and highly selective immune response

1 reference

https://pubmed.ncbi.nlm.nih.gov/29467919

12 December 2020

Interleukin-13 peptide kinoid vaccination attenuates allergic inflammation in a mouse model of asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/29467919

12 December 2020

Fully synthetic self-adjuvanting thioether-conjugated glycopeptide-lipopeptide antitumor vaccines for the induction of complement-dependent cytotoxicity against tumor cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/29467919

12 December 2020

A fully synthetic four-component antitumor vaccine consisting of a mucin glycopeptide antigen combined with three different T-helper-cell epitopes

1 reference

https://pubmed.ncbi.nlm.nih.gov/29467919

12 December 2020

10.18632/ONCOTARGET.19950

Identifiers

DOI

1 reference

http://europepmc.org/abstract/PMC/5805505

28 February 2018

PMC publication ID

5805505

1 reference

http://europepmc.org/abstract/PMC/5805505

28 February 2018

PubMed publication ID

29467919

1 reference